Evidence map›Paper›PMID 39408055›Full record

ArticleJournal of clinical medicine2024

Estetrol Inhibits the Prostate Cancer Tumor Stimulators FSH and IGF-1.

Herjan J T Coelingh Bennink, Erik P M Roos, R Jeroen A van Moorselaar, Harm H E van Melick, Diederik M Somford, Ton A Roeleveld, Tjard D de Haan, Yacov Reisman, Iman J Schultz, Jan Krijgh and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Herjan J T Coelingh BenninkPantarhei Oncology, 3700 AL Zeist, The Netherlands.ORCID 0000-0003-1550-9400
Erik P M RoosDepartment of Urology, Antonius Hospital, 8601 ZK Sneek, The Netherlands.
R Jeroen A van MoorselaarDepartment of Urology, Amsterdam UMC, Free University, 1081 HV Amsterdam, The Netherlands.
Harm H E van MelickDepartment of Urology, St. Antonius Hospital, 3435 CM Nieuwegein, The Netherlands.
Diederik M SomfordDepartment of Urology, Canisius-Wilhelmina Hospital, 6532 SZ Nijmegen, The Netherlands.ORCID 0000-0002-5277-6586
Ton A RoeleveldDepartment of Urology, North-West Hospital, 1815 JD Alkmaar, The Netherlands.
Tjard D de HaanDepartment of Urology, Isala Hospital, 8025 AB Zwolle, The Netherlands.
Yacov ReismanFlare-Health, 1012 DA Amsterdam, The Netherlands.ORCID 0000-0002-1513-6360
Iman J SchultzPantarhei Oncology, 3700 AL Zeist, The Netherlands.ORCID 0000-0001-7113-1188
Jan KrijghPantarhei Oncology, 3700 AL Zeist, The Netherlands.
Frans M J DebruyneAndros Clinics, 6803 AA Arnhem, The Netherlands.

Funding

Pantarhei Oncology Not applicable
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

androgen deprivation therapy (ADT)estetrol (E4)follicle-stimulating hormone (FSH)insulin-like growth factor-1 (IGF-1)PCombi study

Identifiers

PMID39408055
PMCPMC11478095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.